Desq Long
Sign in
SEC FORM 4
—

Barinthus Biotherapeutics plc. (BRNS)

Acquisition (code A) of 361,530 shares; price not stated (see filing).

Reporting Person Hooftman Leon · Officer Title Chief Medical Officer · Transaction Code A

Traded Sep 9, 2026 · Disclosed Sep 9, 2026

Source: SEC Form 4 · 0001104659-26-106338 · filed 2026-09-09 · View filing →

Composed from the Form 4 as filed with the SEC. Share counts, prices and dates are the filing's own; the disclosure lag is counted in business days from the transaction date to the filing date. What is a Form 4?

Cite this card

Desq Long. "Barinthus Biotherapeutics plc. (BRNS)." Disclosed 2026-09-09. https://desqlong.com/cards/0001104659-26-106338-1 (retrieved 2026-09-26).